Marex Group (MRX) director gets 2,070 restricted shares grant

Rhea-AI Filing Summary

Schweinitz Konstantin Graf von reported acquisition or exercise transactions in this Form 4 filing.

Marex Group plc director Schweinitz Konstantin Graf von received an equity grant of 2,070 restricted share awards, each representing a contingent right to one ordinary share upon vesting and settlement. Following this grant, he directly holds 26,165 ordinary shares of Marex Group plc.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schweinitz Konstantin Graf von

Role null

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	2,070	$0.00	--

Holdings After Transaction: Ordinary Shares — 26,165 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted share awards granted: 2,070 shares Transaction price per share: $0.00 per share Total shares after transaction: 26,165 shares +1 more

4 metrics

Restricted share awards granted 2,070 shares Equity grant on 2026-06-09

Transaction price per share $0.00 per share Grant/award acquisition, not open-market purchase

Total shares after transaction 26,165 shares Ordinary shares directly held following the grant

Acquire transactions in filing 1 transaction Non-derivative grant/award acquisition

Key Terms

restricted share awards, contingent right, vesting and settlement, ordinary shares

4 terms

restricted share awards financial

"includes 2,070 shares underlying restricted share awards granted to the Reporting Person"

Restricted share awards are grants of company stock given to employees or executives that cannot be sold or transferred until certain conditions—typically staying with the company for a set time or meeting performance goals—are met. They matter to investors because they can dilute existing shares when they vest, signal management’s incentives and confidence, and affect a company’s future earnings per share much like a delayed paycheck that becomes available only after you meet agreed milestones.

contingent right financial

"Each award represents a contingent right to receive one (1) ordinary share"

vesting and settlement financial

"upon vesting and settlement of the applicable award"

ordinary shares financial

"The number of ordinary shares reported herein includes 2,070 shares underlying"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schweinitz Konstantin Graf von

(Last) (First) (Middle)

C/O MAREX GROUP PLC, 155 BISHOPSGATE

(Street)

LONDON UNITED KINGDOM EC2M 3TQ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Marex Group plc [ MRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/09/2026		A		2,070	A	$0	26,165(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

	/s/ Scott Linsley as Attorney-in-Fact, for Konstantin Graf von Schweinitz	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Marex Group (MRX) report for Konstantin Graf von Schweinitz?

Marex Group reported that director Schweinitz Konstantin Graf von received 2,070 restricted share awards. Each award represents a contingent right to one ordinary share, increasing his direct holdings to 26,165 ordinary shares after the grant.

How many Marex Group (MRX) shares were granted in this Form 4 filing?

The filing shows a grant of 2,070 ordinary share-based awards at a price of $0.00 per share. These are restricted share awards, each potentially becoming one ordinary share when the vesting and settlement conditions are met.

What are the director’s total Marex Group (MRX) holdings after this equity grant?

After the 2,070 restricted share awards were granted, Schweinitz Konstantin Graf von directly holds 26,165 ordinary shares. This total includes the shares underlying the restricted share awards that may be delivered upon vesting and settlement of the awards.

Are the 2,070 Marex Group (MRX) shares immediately available to the director?

The 2,070 awards are restricted share awards that vest over time. Each award is a contingent right to receive one ordinary share upon vesting and settlement, so the shares are not immediately freely available until those conditions are satisfied.

Was any purchase price paid for the Marex Group (MRX) restricted share awards?

The transaction price per share is reported as $0.00, indicating a grant or award rather than a market purchase. This reflects typical equity compensation, where shares are awarded subject to vesting conditions rather than bought in the open market.